Uppsala Monitoring Centre

24/04/2026

💉 It's !

Vaccines have long been one of the most powerful tools in , helping to protect people and their communities from vaccine-preventable diseases for generations.

Safety surveillance, public awareness, and sharing accurate information are crucial to building trust and ensuring for generations to come.

Have questions about vaccines? Visit the World Health Organization (WHO)'s Vaccine Information Hub for evidence-based information and resources 👉 https://ow.ly/l5hv50YOVzR

23/04/2026

Contributing to patient safety and beating hearts through 🫀

From a stent threaded into a coronary artery to an ECG monitor, most patients at Instituto Nacional de Cardiología Ignacio Chávez (INC), a cardiology hospital in Mexico🇲🇽, will encounter a during their treatment. To better detect, analyse, and monitor medical device-related incidents, the IMC implemented a dedicated technovigilance centre.

Learn how the INC's efforts have gone beyond detecting safety problems to actively preventing medical device-related harm and keeping hearts beating in 👉 https://ow.ly/BR1S50YNPC4

22/04/2026

Routine health data, including register-based health records, are a complementary resource in signal detection and assessment, yet remain underutilized in real-world signal management. A new research poster, presented at the European OHDSI Symposium, introduces the SWEEP cohort and its goal to facilitate the future real-time integration of routine health data into pharmacovigilance signal management workflows.

Access the poster in our Research library today 👉 https://ow.ly/F1SO50YNqwO

20/04/2026

🎥 At the heart of Brazil🇧🇷's system since 2018, VigiFlow has combined national oversight with decentralised reporting to strengthen the safety surveillance of medicines and vaccines.

UMC has worked closely with Anvisa to provide the tools and training to enhance the national pharmacovigilance system, helping regional PV centres and healthcare facilities improve adverse event reporting, monitoring, and case management at the district level.

Local stakeholders, including Anvisa, regional PV centres, hospitals, and specialist healthcare providers, share how they are utilising the key features of to collaborate in multidisciplinary teams, improve communication, implement safeguards, and, above all, foster a culture of .

👀 Watch the film below👇 to learn more, and explore the rest of the series on YouTube 👉 ow.ly/j81o50QPVtJ

19/04/2026

The liver is a major metabolic organ responsible for many essential functions, including metabolising medicines. However, some drugs and their compounds may end up damaging the liver, resulting in drug-induced liver injury ( ).

From the archive, Rita Baião shares what professionals should know when it comes to DILI.

🎧 Listen now 👉 https://ow.ly/UpcA50Qx6VT

17/04/2026

Many people use complementary medicines, such as vitamins, minerals, probiotics, and herbal products, for daily self-care. However, many consumers assume that “natural equals safe” and are unaware that high doses, product stacking, and unclear labelling can quietly increase the risk of harm.

Thilini R Thrimawithana and Kaveh Naseri share what vitamin B6 and turmeric can teach us about complementary medicines and offer strategies for their safe use in .

Read more 👉 https://ow.ly/RatC50YKWPC

15/04/2026

📆 Mark your calendars for 2026!

We're teaming up with medicines regulators, national pharmacovigilance centres, and international organisations around the world to increase recognition and reporting of suspected side effects to medicines and vaccines.

This year's campaign will take place from 𝟮 𝘁𝗼 𝟴 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿 𝟮𝟬𝟮𝟲 under the theme "𝘚𝘪𝘥𝘦 𝘦𝘧𝘧𝘦𝘤𝘵𝘴 – 𝘥𝘰𝘯'𝘵 𝘪𝘨𝘯𝘰𝘳𝘦 𝘵𝘩𝘦𝘮, 𝘳𝘦𝘱𝘰𝘳𝘵 𝘵𝘩𝘦𝘮!"

Stay tuned to our channels for more updates and visit our website to learn how you can take part in the campaign 👉 https://who-umc.org/medsafetyweek/

15/04/2026

We're packing our bags for Windhoek, Namibia 🇳🇦, and 🌍

From an educational workshop to an insightful presentation and informative booth, UMC will have an active presence at this year's ISoP Africa Chapter meeting. Join Federica Santoro, Alem Zekarias, and colleagues to learn more about effective communication in and how is used to detect, analyse, and monitor substandard and falsified medical products ( ) reported worldwide.

Join Federica on:
📆 Monday, 18 May 2026
🕑 14:00 CAT

Join Alem on:
📆 Wednesday, 20 May 2026
🕚 11:40 CAT

❗️Register by 17 April to secure your spot at the early-bird rate.

Learn more about the event and register today👉 https://isopafrica.com/

14/04/2026

The latest newsletter is now available 📩

This edition includes translations of key CIOMS documents, a framework for assessing the trustworthiness of scientific research findings, winners of the CIOMS student awar, and more.

Read it today 👉 https://ow.ly/8HVc50YIF0V

14/04/2026

📣 Last chance to submit your abstract for !

Join ISoP Online for the 25th Global Meeting in San José, Costa Rica🇨🇷, as this year's theme explores "Ecosystems of trust: Pharmacovigilance for a healthier world."

Researchers, regulators, industry experts, students, and all professionals are invited to submit abstracts that will contribute to global drug safety.

❗️The deadline to apply is 20 April 2026

More information in the post below 👇

13/04/2026

The Vigi side revealed 🌑

With Artemis II safely back on Earth, its great voyage has illuminated more than just the far side of the Moon. In the same spirit of exploration, the constellation of pharmacovigilance tools equips regulatory authorities with a comprehensive national toolkit for monitoring the safety of medicines and vaccines.

Our case management system, together with its connected applications, provides WHO PIDM members with an integrated system for collecting, managing, and analysing safety data.

🚀 Liftoff to the Vigiverse in the images below 👇 and discover how this toolkit is helping to strengthen worldwide here: https://who-umc.org/vigiverse/

13/04/2026

For , Michael Barras and Nazanin Ghahreman-Falconer describe how their research team in Australia🇦🇺 is turning to to improve the safe dosing of unfractionated heparin (UFH), an anticoagulant that is notoriously difficult to dose correctly and linked to serious side effects.

They hope their work will lead to more sophisticated dosing strategies that enhance the safety and effectiveness of care in everyday clinical practice.

Read more at the link below👇

An Australian research team is using artificial intelligence to improve the safe dosing of unfractionated heparin, a high-risk drug linked to serious side effects.